Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.

Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.

Item
http://www.wikidata.org/entity/Q43611004
Intramitochondrial signaling: interactions among mitoKATP, PKCepsilon, ROS, and MPTPolyphenol (-)-epigallocatechin gallate during ischemia limits infarct size via mitochondrial K(ATP) channel activation in isolated rat heartsMitochondrial matrix K+ flux independent of large-conductance Ca2+-activated K+ channel openingDiversity of mitochondria-dependent dilator mechanisms in vascular smooth muscle of cerebral arteries from normal and insulin-resistant rats.Mitochondrial mechanisms in cerebral vascular control: shared signaling pathways with preconditioning.Evidence for mitochondrial K+ channels and their role in cardioprotection.Selective thyroid hormone receptor-beta activation: a strategy for reduction of weight, cholesterol, and lipoprotein (a) with reduced cardiovascular liability.Depolarization of mitochondria in endothelial cells promotes cerebral artery vasodilation by activation of nitric oxide synthaseMitochondrial-mediated suppression of ROS production upon exposure of neurons to lethal stress: mitochondrial targeted preconditioning.Cardioprotective signaling to mitochondriaMitochondrial calcium homeostasis as potential target for mitochondrial medicine.Modulation of Cardiac Potassium Current by Neural Tone and Ischemia.
P2860

Pharmacologic characterization of BMS-191095, a mitochondrial K(ATP) opener with no peripheral vasodilator or cardiac action potential shortening activity.

Item
http://www.wikidata.org/entity/Q43611004
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh
2001年學術文章
@zh-hant
name
Pharmacologic characterization ...... potential shortening activity.
@en
Pharmacologic characterization ...... potential shortening activity.
@nl
type
label
Pharmacologic characterization ...... potential shortening activity.
@en
Pharmacologic characterization ...... potential shortening activity.
@nl
prefLabel
Pharmacologic characterization ...... potential shortening activity.
@en
Pharmacologic characterization ...... potential shortening activity.
@nl
P1433
P1476
P2093
P304
P31
P407
P433
P478
P50
P577
P698
P1433
P1476
Pharmacologic characterization ...... potential shortening activity
@en
P2093
P304
P31
P407
P433
P478
P50
P577
P698